We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Cancels ODAC Meeting on Two Drugs With Accelerated Approvals; Science Publishes Report Showing Confirmatory Trials Often Don’t Happen for the Drugs
FDA Cancels ODAC Meeting on Two Drugs With Accelerated Approvals; Science Publishes Report Showing Confirmatory Trials Often Don’t Happen for the Drugs
The FDA canceled its scheduled Oncologic Drugs Advisory Committee (ODAC) meeting last week during which it had planned to discuss two cancer drugs that hold accelerated approvals (AA).